Statewide
Michigan Department of Health & Human Services, Bureau of Emergency Preparedness, EMS and Systems of Care
Michigan Department of Health & Human Services, Bureau of Emergency Preparedness, EMS and Systems of Care (MI) carries 28 drugs across 61 dose entries in its current published protocol, effective 2023-01-01.
The current listed document is more than 24 months old and may be outdated.
Drugs and doses28
Acetaminophen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 800 mg | PO | not captured | standing | pages 9, 11, 13, 15, 17, 19, 21, 23, 25, 27 |
| Other | peds | 44.8 mg | PO | not captured | standing | pages 9, 11, 13, 15, 17, 19, 21, 23, 25, 27 |
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| SVT | adult | 6 mg | IV/IO | not captured | standing | pages 8, 10, 12, 14, 16, 18, 20, 22, 24, 26 |
| SVT | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 8, 10, 12, 14, 16, 18, 20, 22, 24, 26 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2.5 mg | NEB | not captured | standing | pages 9, 11, 13, 15, 17, 19, 21, 23, 25, 27 |
| Asthma / bronchospasm | peds | 2.5 mg | NEB | not captured | standing | pages 9, 11, 13, 15, 17, 19, 21, 23, 25, 27 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 150 mg | IV | not captured | standing | page 26 |
| Other | adult | 300 mg | IV/IO | not captured | standing | pages 8, 10, 12, 14, 16, 18, 20, 22, 24, 26 |
| Other | peds | 5 mg/kg | IV/IO | not captured | standing | pages 8, 10, 12, 14, 16, 18, 20, 22, 24, 26 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 1 mg | IV/IO | not captured | standing | pages 8, 10, 12, 14, 16, 18, 20, 22, 24, 26 |
| Bradycardia | peds | 0.02 mg/kg | IV/IO | not captured | standing | pages 8, 10, 12, 14, 16, 18, 20, 22, 24, 26 |
| Nerve agent exposure | adult | 4–6 mg | IV/IO/IM | not captured | standing | page 28 |
| Nerve agent exposure | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 28 |
Cefazolin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Trauma / hemorrhage | adult | 2 g | IV | not captured | standing | pages 9, 11, 13, 15, 17, 19, 21, 23, 25, 27 |
| Trauma / hemorrhage | peds | 150–1000 mg | IV | not captured | standing | pages 9, 11, 13, 15, 17, 19, 21, 23, 25, 27 |
Ceftriaxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Trauma / hemorrhage | adult | 2 g | IV | not captured | standing | pages 11, 13, 15, 17, 19, 21, 23, 25, 27 |
| Trauma / hemorrhage | peds | 300–1700 mg | IV | not captured | standing | pages 11, 13, 15, 17, 19, 21, 23, 25, 27 |
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 25 g | IV | not captured | standing | pages 9, 11, 13, 15, 17, 19, 21, 23, 25 |
| Hypoglycemia | peds | 2.5 g | IV | not captured | standing | pages 9, 11, 13, 15, 17, 19, 21, 23, 25 |
Diazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Procedural sedation | adult | 5–10 mg | IV | not captured | standing | page 27 |
Diltiazem
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 20 mg | IV | not captured | standing | page 26 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 50 mg | IV/IO/IM | not captured | standing | pages 9, 11, 13, 15, 17, 19, 21, 23, 25 |
| Anaphylaxis | peds | 15 mg | IV/IO/IM | not captured | standing | pages 9, 11, 13, 15, 17, 19, 21, 23, 25 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.3 mg | IM | not captured | standing | pages 9, 11, 13, 15, 17, 19, 21, 23, 25, 27 |
| Other | peds | 0.01 mg/kg | IV/IO | not captured | standing | pages 8, 10, 12, 14, 16, 18, 20, 22, 24, 26 |
| Stridor | peds | 5 mg | NEB | not captured | standing | pages 9, 11, 13, 15, 17, 19, 21, 23, 25 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 50–100 mcg | IV/IN | not captured | standing | pages 9, 13, 15, 17, 19, 21, 23, 25, 27 |
| Mild to moderate pain | peds | 10–20 mcg | IV/IN | not captured | standing | pages 9, 13, 15, 17, 19, 21, 23, 25, 27 |
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 1 mg | IM | not captured | standing | pages 9, 11, 13, 15, 17, 19, 21, 23, 25, 27 |
| Hypoglycemia | peds | 0.5 mg | IM | not captured | standing | pages 9, 11, 13, 15, 17, 19, 21, 23, 25, 27 |
Hydroxocobalamin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cyanide poisoning | adult | 5000 mg | IV/IO | not captured | standing | page 29 |
| Cyanide poisoning | peds | 250 mg | IV/IO | not captured | standing | page 29 |
Ibuprofen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 600 mg | PO | not captured | standing | pages 13, 15, 17, 19, 21, 23, 25, 27 |
| Other | peds | 80–300 mg | PO | not captured | standing | pages 13, 15, 17, 19, 21, 23, 25, 27 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 500 mcg | NEB | not captured | standing | pages 9, 11, 13, 15, 17, 19, 21, 23, 25, 27 |
| Asthma / bronchospasm | peds | 500 mcg | NEB | not captured | standing | pages 9, 11, 13, 15, 17, 19, 21, 23, 25, 27 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 200–400 mg | IM | not captured | standing | page 27 |
| Mild to moderate pain | adult | 10–20 mg | IV/IO | not captured | standing | pages 25, 27 |
| Mild to moderate pain | adult | 30–50 mg | IN | not captured | standing | pages 15, 17, 19, 21, 23, 25, 27 |
| Mild to moderate pain | peds | 10 mg | IV/IO | not captured | standing | pages 25, 27 |
| Mild to moderate pain | peds | 10–30 mg | IN | not captured | standing | pages 15, 17, 19, 21, 23, 25, 27 |
| Procedural sedation | adult | 75–150 mg | IV | not captured | standing | page 27 |
Ketorolac
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 15 mg | IV/IM | not captured | standing | pages 21, 23, 25, 27 |
| Mild to moderate pain | peds | 10.5 mg | IV/IM | not captured | standing | pages 21, 23, 25, 27 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 100 mg | IV/IO | not captured | standing | pages 8, 10, 12, 14, 16, 18, 20, 22, 24, 26 |
| Other | peds | 1 mg/kg | IV/IO | not captured | standing | pages 8, 10, 12, 14, 16, 18, 20, 22, 24, 26 |
Methylprednisolone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 125 mg | IV/IO/IM | not captured | standing | pages 9, 11, 13, 15, 17, 19, 21, 23, 25 |
| Anaphylaxis | peds | 10 mg | IV/IO/IM | not captured | standing | pages 9, 11, 13, 15, 17, 19, 21, 23, 25 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Procedural sedation | adult | 1–5 mg | not captured | not captured | standing | page 27 |
| Seizure | adult | 10 mg | IM | not captured | standing | pages 9, 11, 13, 15, 17, 19, 21, 23, 25 |
| Seizure | adult | 5 mg | IV | not captured | standing | pages 9, 11, 13, 15, 17, 19, 21, 23, 25 |
Morphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 4–5 mg | IV/IO/IM | not captured | standing | pages 17, 19, 21, 23, 25, 27 |
| Mild to moderate pain | peds | 2 mg | IV/IO/IM | not captured | standing | pages 17, 19, 21, 23, 25, 27 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Opioid overdose | adult | 2 mg | IV/IM | not captured | standing | pages 9, 11, 13, 15, 17, 19, 21, 23, 25, 26 |
| Opioid overdose | peds | 0.5–2 mg | IV/IM | not captured | standing | pages 9, 11, 13, 15, 17, 19, 21, 23, 25, 26 |
Nerve Agent Antidote Kit
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nerve agent exposure | adult | 2 to 3 | IM | not captured | standing | page 28 |
| Nerve agent exposure | peds | 1 | IM | not captured | standing | page 28 |
Prednisone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 50 mg | PO | not captured | standing | pages 23, 25, 27 |
| Anaphylaxis | peds | 50 mg | PO | not captured | standing | pages 23, 25, 27 |
Racemic Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Stridor | peds | 11.25 mg | NEB | not captured | standing | pages 9, 11, 13, 15, 17, 19, 21, 23, 25 |
Verapamil
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 5 mg | IV | not captured | standing | page 26 |